Stay updated on Talquetamab Pre-Approval Access in Myeloma Clinical Trial

Sign up to get notified when there's something new on the Talquetamab Pre-Approval Access in Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Talquetamab Pre-Approval Access in Myeloma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added, replacing v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T14:07:16.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T23:44:16.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision: v3.4.3 has been added and Revision: v3.4.2 has been removed.
    Difference
    0.1%
    Check dated 2026-03-12T20:21:19.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Version update from v3.4.1 to v3.4.2 with no visible changes to the study record or page content.
    Difference
    0.1%
    Check dated 2026-02-12T01:40:24.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.1 and no longer shows Revision: v3.4.0, which is an internal versioning update that does not affect content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:36:15.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The changes are limited to UI/text updates and versioning, including a new 'Show glossary' option and minor wording/capitalization adjustments to labels such as 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-28T21:32:23.000Z thumbnail image

Stay in the know with updates to Talquetamab Pre-Approval Access in Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Talquetamab Pre-Approval Access in Myeloma Clinical Trial page.